7 studies found for:    milk thistle | NCCAM
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
Condition: Chronic Hepatitis C
Interventions: Drug: Silymarin;   Other: Placebo
2 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
3 Unknown  An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions
Condition: Healthy
Intervention:
4 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
5 Completed Botanical/Drug Interactions in HIV: Glucuronidation
Condition: HIV Seronegativity
Intervention: Drug: silymarin
6 Completed Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Oxidative Stress
Interventions: Drug: silymarin;   Dietary Supplement: green tea extract (EGCG)
7 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active

Indicates status has not been verified in more than two years